The SSADH Association is a voluntary, not-for-profit, 501(c) (3) organization dedicated to helping children and families affected by an ultra-rare neurometabolic disorder known as Succinic Semialdehyde Dehydrogenase Deficiency or SSADH.
The SSADH Association is committed to those affected with this neurotransmitter disease through education, advocacy and research.
News & Updates
The 2020 Virtual SSADH Conference held July 9 and 10, was made up of two half day events including formal presentations by outstanding clinicians and researchers in the field from around the world, allowing for a question and answer session at the end of each speaker.
The goal of the conference was to share updates from the on-going Natural History Study, encourage brainstorming between researchers and clinicians and discuss the best directions for future research moving forward. A portion of the agenda was devoted to update families and caregivers of SSADH patients.
The proceeding from this event will be published in the Journal of Child Neurology at a later date.
Below are the links to the recording for each session. The recordings will be available until early 2021.
2020 SSADH Conference - Session 1
2020 SSADH Conference - Session 2
2020 SSADH Conference - Session 3
2020 SSADH Conference - Session 4
Conference Organizers: Dr. Jean-Baptiste Roullet, Dr. K. Michael Gibson
Dr. Phillip Pearl, Dr. Melissa DiBacco, Alice McConnell, & Carolyn Hoffman